Holen Sie sich die Stockscreener-App
1.70
0.58%
-0.01
Vorhandelsmarkt:
1.56
-0.14
-8.24%
Intelligent Bio Solutions Inc Aktie (INBS) Neueste Nachrichten
INBS: Innovative drug screening system targets U.S. entry with rapid, non-invasive testing and strong growth - TradingView
INBS: Innovative fingertip drug screening targets U.S. entry with FDA review and rapid expansion plans - TradingView
INTELLIGENT BIO SOLUTIONS INC. SEC Filing (Sep 24, 2026) - Stock Titan
Form 4 Intelligent Bio Solutions Inc For: 23 September By Investing.com - Investing.com UK
Intelligent Bio Solutions resolves all cybersecurity review items ahead of H2 2026 FDA filing - scanx.trade
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
Intelligent Bio (Nasdaq: INBS) may get up to $9.82M if resale-linked warrants are exercised - Stock Titan
Intelligent Bio (INBS) closes new private funding round - stocktitan.net
Intelligent Bio Solutions Shares Outstanding Reach 3,316,803 - minichart.com.sg
Form 8K Intelligent Bio Solutions Inc For: 11 September By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions updates outstanding shares count following warrant exercises - Investing.com
Intelligent Bio Solutions updates shares outstanding to 3,316,803 following warrant exercises - tradingview.com
Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET - The Manila Times
A fingerprint drug test company will discuss its FDA submission Sept. 24 - stocktitan.net
Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4: 30 p.m. ET - marketscreener.com
Intelligent Bio Solutions submits FDA application for codeine test By Investing.com - Investing.com South Africa
Intelligent Bio Solutions Files FDA 510(k) for U.S. Market Entry - Minichart
INBS Looks 7.4% Undervalued on GF Value™ Amid Challenging Price-to-Sales Dynamics - GuruFocus
Intelligent Bio Solutions submits FDA 510(k) for fingerprint drug screen after clinical studies show >98% accuracy - TradingView
Intelligent Bio Solutions submits FDA application for codeine test - Investing.com
Intelligent Bio Solutions Submits FDA 510(k) for Drug Screening System to Detect Codeine - Quiver Quantitative
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance - marketscreener.com
Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market - Benzinga
A fingerprint drug test ruled out codeine in every negative sample. It was submitted to the FDA. - Stock Titan
Intelligent Bio Solutions Advances FDA Drug Screening Filing - TipRanks
Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Intelligent Bio Solutions Raises Up to $15M in Private Placement - minichart.com.sg
Intelligent Bio Solutions Completes $5 Million Private Placement - TipRanks
Intelligent Bio Solutions Raises $5 Million in Private Placement With Warrants - TradingView
INBS|Intelligent Bio Solutions Inc|Price:2.300|Chg%:-0.170 - TradingKey
Intelligent Bio Solutions Inc. announced that it has received $4.999998 million in funding - marketscreener.com
Intelligent Bio Solutions posts >98% accuracy in multi-site study, targets Sept 2026 510(k) - TradingView
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Intelligent Bio Solutions Inc. announced that it expects to receive $4.999998 million in funding - marketscreener.com
INBS Stock Draws Traders As FDA 510(k) Milestones Pile Up - StocksToTrade
INBS Stock Steadies As FDA Milestones And Revenue Growth Stack Up - timothysykes.com
INBS Looks 3.4% Overvalued on GF Value™ - GuruFocus
Intelligent Bio Solutions reports improved drug screening accuracy - Investing.com India
Intelligent Bio Solutions reports improved drug screening accuracy By Investing.com - Investing.com Canada
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission - The Manila Times
Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules - The Manila Times
Intelligent Bio Solutions raises $5M in private placement By Investing.com - Investing.com Nigeria
A fingerprint drug test produced no false positives. Intelligent Bio Solutions expects an FDA filing in September. - Stock Titan
Press Release: Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules - Moomoo
Intelligent Bio Solutions posts investor presentation on fingerprint sweat drug testing system - Bitget
Intelligent Bio Solutions(INBS) Stock Options Chain | Quotes & News - Moomoo
Intelligent Bio Solutions earnings missed by $4.88, revenue fell short of estimates - Investing.com Canada
Intelligent (INBS) Range: Posts a 1.31% Loss to $2.63 in the Latest Reading; Chart View: $2.50 and $2.76 Define the Nearby Reference Levels in the Current UpdateSize Factor - vinanet.vn
Intelligent Bio Solutions completes clinical data collection for FDA 510(k) - scanx.trade
INBS Looks 0.4% Overvalued on GF Value™ - GuruFocus
Intelligent Bio Solutions Revenue Rises 38% to $4.2 Million in Fiscal 2026 - Moomoo
Intelligent Bio Solutions revenue rises 38% to $4.2 million - grafa.com
BRIEF-Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth - Bitget
Form 8K Intelligent Bio Solutions Inc For: 19 August By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions Inc. Reports Earnings Results for the Full Year Ended June 30, 2026 - marketscreener.com
INBS FY26 Results: Revenue up 38% to $4.2M, margin expands to 48.6% - scanx.trade
Intelligent Bio Solutions Revenue Jumps 38% as Gross Margin Expands 778 Basis Points - Minichart
1.51%
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):